Accuracy of Preoperative Positron Emission Tomography – Computed Tomography for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer
The Thoracic and Cardiovascular Surgeon · 01.09.2026 · 74 (06) · 510-517
DOI: 10.1055/a-2855-2535 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.09.2026. Verfasst von Sarah Häufglöckner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Klinikum Darmstadt, Darmstadt, Hessen, Germany. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Positron Emission Tomography Computed Tomography, Lymph Nodes. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Accurate mediastinal lymph node staging is essential in non-small cell lung cancer (NSCLC) treatment. While 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is widely used for noninvasive staging, its diagnostic reliability, particularly for nodal assessment, remains debated. A retrospective multicenter analysis included 278 patients with histologically confirmed NSCLC who underwent FDG-PET/CT followed by surgery with systematic lymphadenectomy between 2015 and 2021. PET/CT-based nodal staging was compared with histopathology. Diagnostic performance was evaluated using sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), and Cohen's κ. Logistic regression was performed to identify predictors of correct N staging. Patients receiving neoadjuvant therapy were excluded from subgroup analyses (n = 252). Histopathology revealed nodal metastases in 112 patients (40.3%). PET/CT detected nodal involvement with sensitivity of 66.8% and specificity of 85.2%. PPV was 50.7% and NPV 85.5%, with an overall concordance of 43.3%. Sensitivity for N1 disease was 38.2%, whereas N2 and N3 metastases were detected with sensitivities of 55.3% and 100.0%. The false-negative rate was 25.2%, with intrapulmonary nodes (station 11) most frequently missed. False-positive findings occurred in 20.1%, predominantly in hilar nodes. Multivariable analysis identified lymph node involvement and tumor stage as independent predictors of staging accuracy, whereas extracapsular extension showed a non-significant trend. FDG-PET/CT demonstrates high specificity and NPV but limited sensitivity for mediastinal nodal staging in NSCLC under real-world conditions. These findings are primarily driven by disease characteristics rather than methodological factors. A multimodal approach remains essential, with histopathological confirmation of PET-positive findings and selective invasive staging in PET-negative patients to ensure accurate treatment allocation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Klinikum Darmstadt, Darmstadt, Hessen, Germany.
- Department of Thoracic Surgery, Sana Klinikum Offenbach GmbH, Offenbach, Hessen, Germany.
- Department of Pneumology, Sana Klinikum Offenbach GmbH, Offenbach, Hessen, Germany.
- Institute of Biostatistics and Mathematical Modeling, Universitätsklinikum Frankfurt, Frankfurt, Hessen, Germany.
ORCID-Profile: Sarah Häufglöckner
Zitieren
APA
Häufglöckner, S., Kleine, P., Althoff, A., & Lingwal, N. (2026). Accuracy of Preoperative Positron Emission Tomography – Computed Tomography for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer. The Thoracic and Cardiovascular Surgeon, 74(06), 510-517. https://doi.org/10.1055/a-2855-2535
Vancouver
Häufglöckner S, Kleine P, Althoff A, Lingwal N. Accuracy of Preoperative Positron Emission Tomography – Computed Tomography for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer. The Thoracic and Cardiovascular Surgeon. 2026;74(06):510-517. doi:10.1055/a-2855-2535
BibTeX
@article{Hufglckner2026,
author = {Häufglöckner, Sarah and Kleine, Peter and Althoff, André and Lingwal, Neelam},
title = {Accuracy of Preoperative Positron Emission Tomography – Computed Tomography for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {06},
pages = {510--517},
doi = {10.1055/a-2855-2535}
}
EUVIMED